Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma

被引:31
作者
Fan, Mingming [1 ]
Shen, Jun [2 ]
Liu, Hu [1 ]
Wen, Zhijian [3 ]
Yang, Jue [1 ]
Yang, Pinghua [1 ]
Liu, Kai [1 ]
Chang, Yanxin [1 ]
Duan, Jicheng [1 ]
Lu, Kai [1 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Laparoscopy, 225 Changhai Rd, Shanghai 200438, Peoples R China
[2] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 1, Shanghai, Peoples R China
[3] 174 Hosp PLA, Dept Hepatobiliary Pancreat Vasc Surg, Xiamen, Fujian, Peoples R China
关键词
PRRX1; p53; prognosis; hepatocellular carcinoma; EPITHELIAL-MESENCHYMAL TRANSITION; P53; METASTASIS; CANCER; INDUCER; CELLS;
D O I
10.3892/or.2017.5785
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Paired-related homeobox 1 (PRRX1) has been identified as a novel molecule associated with induction of epithelial-mesenchymal transition (EMT), acquisition of cancer stem cell like properties and poor prognosis in tumors. However, the function of PRRX1 in hepatocellular carcinoma has not been elucidated. In the present study, we observed that PRRX1 expression levels were downregulated and positively correlated with the downregulated expression of p53 in hepatocellular carcinoma specimens. Decreased expression of PRRX1 and/or p53 by siRNA induced both the migration and the invasion features of HCC cells in vitro. Furthermore, the loss of PRRX1 inhibits hepatocellular carcinoma (HCC) cell apoptosis, an anti-apoptotic expression profile was upregulated accompanied by downregulated expression of p53. HCC patients with low-expression of both PRRX1 and p53 had a significantly shorter overall and disease-free survival. These findings demonstrate that PRRX1 plays an important role in metastasis and apoptosis of HCC cells through the p53-dependent signaling pathway and is expected to become a novel biomarker associated with patient prognosis and survival.
引用
收藏
页码:1083 / 1090
页数:8
相关论文
共 24 条
[1]   Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast Cancer [J].
Bae, Young Kyung ;
Choi, Jung Eun ;
Kang, Su Hwan ;
Lee, Soo Jung .
JOURNAL OF BREAST CANCER, 2015, 18 (03) :256-263
[2]   Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[3]   Specific GATA Factors Act as Conserved Inducers of an Endodermal-EMT [J].
Campbell, Kyra ;
Whissell, Gavin ;
Franch-Marro, Xavier ;
Batlle, Eduard ;
Casanova, Jordi .
DEVELOPMENTAL CELL, 2011, 21 (06) :1051-1061
[4]   The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death [J].
Chari, Nikhil S. ;
Pinaire, Nicole L. ;
Thorpe, Lynnelle ;
Medeiros, L. Jeffrey ;
Routbort, Mark J. ;
McDonnell, Timothy J. .
APOPTOSIS, 2009, 14 (04) :336-347
[5]   Loss of p53 and Ink4a/Arf cooperate in a cell autonomous fashion to induce metastasis of hepatocellular carcinoma cells [J].
Chen, Ya-Wen ;
Klimstra, David S. ;
Mongeau, Nfichelle E. ;
Tatem, Jessica L. ;
Boyartchuk, Victor ;
Lewis, Brian C. .
CANCER RESEARCH, 2007, 67 (16) :7589-7596
[6]   SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin [J].
Deep, Gagan ;
Jain, Anil K. ;
Ramteke, Anand ;
Ting, Harold ;
Vijendra, Kavitha C. ;
Gangar, Subhash C. ;
Agarwal, Chapla ;
Agarwal, Rajesh .
MOLECULAR CANCER, 2014, 13
[7]   PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer [J].
Guo, Jinbao ;
Fu, Zhongxue ;
Wei, Jinlai ;
Lu, Weidong ;
Feng, Jihong ;
Zhang, Shouru .
MEDICAL ONCOLOGY, 2015, 32 (01) :1-12
[8]   Antibody-mediated p53 protein therapy prevents liver metastasis in vivo [J].
Hansen, James E. ;
Fischer, Laurice K. ;
Chan, Grace ;
Chang, Sophia S. ;
Baldwin, Scott W. ;
Aragon, Robert J. ;
Carter, Jacqueline J. ;
Lilly, Michael ;
Nishimura, Robert N. ;
Weisbart, Richard H. ;
Reeves, Mark E. .
CANCER RESEARCH, 2007, 67 (04) :1769-1774
[9]   Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma [J].
Hirata, Hidenari ;
Sugimachi, Keishi ;
Takahashi, Yusuke ;
Ueda, Masami ;
Sakimura, Shotaro ;
Uchi, Ryutaro ;
Kurashige, Junji ;
Takano, Yuki ;
Nanbara, Sho ;
Komatsu, Hisateru ;
Saito, Tomoko ;
Shinden, Yoshiaki ;
Iguchi, Tomohiro ;
Eguchi, Hidetoshi ;
Atsumi, Kazushige ;
Sakamoto, Katsumi ;
Doi, Toshiro ;
Hirakawa, Masakazu ;
Honda, Hiroshi ;
Mimori, Koshi .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 :S1402-S1409
[10]   The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma [J].
Lewis, BC ;
Klimstra, DS ;
Socci, ND ;
Xu, S ;
Koutcher, JA ;
Varmus, HE .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (04) :1228-1237